Code: 0710-0709
Seraseq® ctDNA EGFR ex19del Mutation Mix (AF0.1%). SeraCare ctDNA reference (AF0.1%) for EGFR-targeted liquid biopsy NGS assay development and validation.
Price on Application
The Seraseq® ctDNA EGFR ex19del Mutation Mix is a purified ctDNA reference material for NGS-based liquid biopsy assays targeting EGFR exon 19 deletion, the most common sensitising EGFR mutation in NSCLC. Formulated at AF0.1% allele frequency, it enables limit-of-detection studies, sensitivity characterisation, and routine quality control of ctDNA detection panels.
Key features:
- Targets clinically actionable EGFR exon 19 deletion, the most common sensitising EGFR mutation in NSCLC
- Allele frequency AF0.1% for sensitivity and LOD characterisation
- Purified ctDNA for direct library preparation input
- Precisely quantitated by digital PCR for reliable, reproducible performance